Abeona Therapeutics (ABEO) Interest & Investment Income (2011 - 2022)
Abeona Therapeutics' (ABEO) quarterly Interest & Investment Income came in at $30000.0 in Q2 2022, up 275.0% year-on-year from $8000.0 in Q2 2021, and up 275.0% quarter-over-quarter from $8000.0 in Q2 2021.
Abeona Therapeutics (ABEO) Interest & Investment Income (2011 - 2022) Analysis & Trends
Abeona Therapeutics' Interest & Investment Income history runs 11 years deep, the most recent figure standing at $30000.0 for Q2 2022.
- On a quarterly basis, Interest & Investment Income rose 275.0% year-over-year to $30000.0 in Q2 2022; TTM through Jun 2022 was $589000.0, a 46.06% decrease from a year earlier, with the FY2018 full-year figure at $1.5 million, up 186.86% from the prior year.
- Interest & Investment Income improved to $30000.0 in Q2 2022 per ABEO's latest filing, from $8000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $533000.0 in Q4 2018 and bottomed at $8000.0 in Q2 2021.
- The 4-year median for Interest & Investment Income is $236500.0 (2018), against an average of $261875.0.
- Across the five-year window, Interest & Investment Income jumped 2280.95% in 2018 and sank 83.6% in 2019, its largest moves.
- Year by year, Interest & Investment Income stood at $533000.0 in 2018, then sank by 90.24% to $52000.0 in 2019, then sank by 84.62% to $8000.0 in 2021, then soared by 275.0% to $30000.0 in 2022.
- Per Business Quant, the three latest ABEO Interest & Investment Income figures stand at $30000.0 (Q2 2022), $8000.0 (Q2 2021), and $52000.0 (Q2 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Abeona Therapeutics | 347.09 Mn | 178.82 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 30,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Jun 30, 2019 | 52,000.00 |
| Mar 31, 2019 | 499,000.00 |
| Dec 31, 2018 | 533,000.00 |
| Sep 30, 2018 | 500,000.00 |
| Jun 30, 2018 | 317,000.00 |
| Mar 31, 2018 | 156,000.00 |
| Dec 31, 2017 | 301,000.00 |
| Sep 30, 2017 | 21,000.00 |
| Jun 30, 2017 | 164,000.00 |
| Mar 31, 2017 | 39,000.00 |
| Dec 31, 2016 | -1.17 Mn |
| Sep 30, 2016 | 2.55 Mn |
| Jun 30, 2016 | 13,000.00 |
| Mar 31, 2016 | 618,000.00 |
| Dec 31, 2015 | 3.92 Mn |
| Sep 30, 2015 | 92,000.00 |
| Jun 30, 2015 | 16,000.00 |
| Mar 31, 2015 | 3,000.00 |